Five-Year Extension Found Just, As Aurobindo Loses On US Sugammadex Appeal
Merck’s Reissued Patent Entitled To Full Patent-Term Extension, Federal Circuit Holds
In a precedential decision, the US Court of Appeals for the Federal Circuit has determined the meaning of the language “the patent” as it applies to patent-term extensions for reissued patents, in the context of Aurobindo’s bid to wipe out a reissued patent shielding Merck & Co’s Bridion (sugammadex) injectable.
